Polarization deepens in drug industry

Published: 2013-08-22 07:00:00

Updated: 2013-08-22 07:00:00

Gone are the times when mid- and small-sized drug firms earned profits easily by producing generics, which refer to drugs that have the same ingredients and effects as the original brand name drugs. They are now on the brink of a precipice.

According to data released yesterday by Yakup.com, a ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK